Intel to Produce Panasonic SoCs Using 14nm Low-Power Manufacturing Process

Intel Corporation today announced that it has entered into a manufacturing agreement with Panasonic Corporation’s System LSI Business Division. Intel’s custom foundry business will manufacture future Panasonic system-on-chips (SoCs) using Intel’s 14nm low-power manufacturing process.

Panasonic’s next-generation SoCs will target audio visual-based equipment markets, and will enable higher levels of performance, power and viewing experience for consumers.

“Intel’s 14nm Tri-Gate process technology is very important to develop the next- generation SoCs,” said Yoshifumi Okamoto, director, Panasonic Corporation SLSI Business Division. “We will deliver highly improved performance and power advantages with next-generation SoCs by leveraging Intel’s 14nm Tri-Gate process technology through our collaboration.”

Intel’s leading-edge 14nm low-power process technology, which includes the second generation of Tri-Gate transistors, is optimized for low-power applications. This will enable Panasonic’s SoCs to achieve high levels of performance and functionality at lower power levels than was possible with planar transistors.

“We look forward to collaborating with the Panasonic SLSI Business Division,” said Sunit Rikhi, vice president and general manager, Intel Custom Foundry. “We will work hard to deliver the value of power-efficient performance of our 14nm LP process to Panasonic’s next-generation SoCs. This agreement with Panasonic is an important step in the buildup of Intel’s foundry business.”

Five other semiconductor companies have announced agreements with Intel’s custom foundry business, including Altera, Achronix Semiconductor, Tabula, Netronome and Microsemi.

Source: http://www.intel.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.